Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1973-5-24
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0003-4819
pubmed:author
pubmed:issnType
Print
pubmed:volume
78
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
491-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:4571565-Acute Kidney Injury, pubmed-meshheading:4571565-Administration, Oral, pubmed-meshheading:4571565-Ammonium Chloride, pubmed-meshheading:4571565-Anti-Bacterial Agents, pubmed-meshheading:4571565-Bacteria, pubmed-meshheading:4571565-Bicarbonates, pubmed-meshheading:4571565-Blood Proteins, pubmed-meshheading:4571565-Clinical Trials as Topic, pubmed-meshheading:4571565-Drug Combinations, pubmed-meshheading:4571565-Fluorometry, pubmed-meshheading:4571565-Half-Life, pubmed-meshheading:4571565-Humans, pubmed-meshheading:4571565-Hydrogen-Ion Concentration, pubmed-meshheading:4571565-Kidney Failure, Chronic, pubmed-meshheading:4571565-Male, pubmed-meshheading:4571565-Protein Binding, pubmed-meshheading:4571565-Pyrimidines, pubmed-meshheading:4571565-Sulfamethoxazole, pubmed-meshheading:4571565-Trimethoprim, pubmed-meshheading:4571565-Ultrafiltration
pubmed:year
1973
pubmed:articleTitle
Trimethoprim-sulfamethoxazole: pharmacodynamic effects of urinary pH and impaired renal function. Studies in humans.
pubmed:publicationType
Journal Article, Clinical Trial, Controlled Clinical Trial